✦ LIBER ✦

Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study

✍ Scribed by Kenneth B. Gordon; Richard G. Langley; Craig Leonardi; Darryl Toth; M. Alan Menter; Sewon Kang; Michael Heffernan; Bruce Miller; Regina Hamlin; Liberata Lim; Jianhua Zhong; Rebecca Hoffman; Martin M. Okun

Book ID: 116581881
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 273 KB
Volume: 55
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2006.05.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of adalimumab in a 1

Efficacy and safety of adalimumab in a 120-week open-label extension study in patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Adalimumab for the treatment of patients

Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

✍ Philip J. Mease; Dafna D. Gladman; Christopher T. Ritchlin; Eric M. Ruderman; Se 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Infliximab monotherapy in Japanese patie

Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial

✍ Torii, Hideshi; Nakagawa, Hidemi 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Once weekly administration of etanercept

Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension

✍ P.C.M. Van De Kerkhof; S. Segaert; M. Lahfa; T.A. Luger; Z. Karolyi; A. Kaszuba; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis

✍ A.B. Gottlieb; R.G. Langley; B.E. Strober; K.A. Papp; P. Klekotka; K. Creamer; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

Patients with psoriasis respond to conti

Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial

✍ Gerald G. Krueger; Boni Elewski; Kim Papp; Andrea Wang; Ralph Zitnik; Angelika J 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 277 KB